Nationwide Fund Advisors - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 64 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 4.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2015$47,000
-4.1%
14,1420.0%0.00%
Q4 2014$49,000
-31.0%
14,1420.0%0.00%
Q3 2014$71,000
-62.6%
14,142
+2.7%
0.00%
-100.0%
Q2 2014$190,00013,7660.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 89,240$255,0000.09%
BT Wealth Management LLC 57,009$163,0000.08%
HighVista Strategies LLC 30,200$86,0000.06%
D.A. DAVIDSON & CO. 840,948$2,405,0000.04%
Iron Gate Global Advisors LLC 17,090$49,0000.03%
Advisor Group, Inc. 799,846$2,287,0000.02%
Virtu Financial LLC 54,738$157,0000.02%
JOYN Advisors, Inc. 12,796$37,0000.01%
Vivaldi Capital Management LP 10,668$31,0000.01%
Ameritas Investment Company, LLC 10,782$31,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders